Efficacy and safety of sacituzumab tirumotecan (sac-TMT) plus pembrolizumab in patients with recurrent or metastatic cervical cancer

2024-09-01

3

PRE

AI

王

王静 (Jing Wang)

R

Ruihua An

黄翼 (Yi Huang)

J

J. Zhang

J

Jeffrey C. Goh

K

Kui Jiang

G

Gongqi Yu

陈

陈良安 (Liangan Chen)

D

Diane Provencher

Y

Yiyun Tang

L

Li, G.

H

H Z Qiu

B

B. Akala

E

Elliot Chartash

周

周勇 (Yi Zhou)

X

Xing Jin

J

Junbo Ge

X

Xiaojiang Wu

DOI：10.1016/j.annonc.2024.08.778

Original

Original request for help

Share

Save